Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol in NAFLD Patients with Type 2 Diabetes
NCT05578404Phase 2Completed
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in non-alcoholic fatty liver disease (NAFLD), sponsored by Tanta University. Started Oct 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT05578404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05578404.